Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...
MUTE-Seq is a new liquid-biopsy method powered by an engineered ultra-precise CRISPR enzyme, FnCas9-AF2, which can ...
News-Medical.Net on MSN
Highly sensitive CRISPR-based method designed to detect low-frequency cancer mutations
Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...
Seq, a CRISPR-based method that enriches ultra-rare tumor DNA in blood by removing background wild-type DNA before sequencing ...
Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its effectiveness is often limited by ...
In a new paper presented at IEDM 2025, imec reports on the successful fabrication of highly uniform nanopores with diameters ...
In a wide-ranging discussion on the future of genomics and cancer diagnostics in India, senior leaders from Strand Life ...
Ansa Biotechnologies Inc., the trusted partner for DNA synthesis, today announced the appointment of Geoff Hamilton as Chief Financial Officer and Chief Business Officer. Mr. Hamilton will report ...
Rainbows, pickleball and puppies: Inside the ‘enduring activism’ and ‘cautious optimism’ at ASH 2025
People come to Orlando to escape. With Disney World, SeaWorld and Universal Studios all in the area, there are endless ...
NEW YORK – A gene therapy using lentiviral particles to generate CAR T cells inside multiple myeloma patients has shown the ability to eliminate the small number of cancer cells in the bone marrow ...
MS. COOPER: Good morning, and welcome to The Washington Post. I’m Gina Cooper, managing director of Washington Post Live. Thank you so much to everyone who’s here in the room joining us this morning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback